BCL2 and Burkitt lymphoma: Although MYC can induce apoptosis under normal conditions, Burkitt lymphoma cells counteract this effect by upregulating anti-apoptotic proteins such as BCL-2 or through mutations that inactivate pro-apoptotic proteins like p53.